Form D · Biotechnology
Prince Biotech, Inc.
Mason, OH · CIK 0002093745
Offering snapshot reported Oct 27, 2025 · SEC filing
- Reported sold
- Yet to sell Offering amount: $10M
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 27, 2025 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-562173
Source: Form D, filed Oct 27, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Huber | Executive |
| Jay Levy | Executive |
| Douglas Prince | Director, Executive |
| Aaron Prince | Executive |
| Steve Sloate | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5496 Winding Cape Way
Mason, OH, 45040
Mason, OH, 45040